NCT03628391.
Trial name or title | Efficacy of halopeRIdol to decrease the burden of Delirium In adult Critically ill patiEnts: a prospective randomized multi‐center double‐blind placebo‐controlled clinical trial (EuRIDICE) |
Methods | Multi‐site (6), quadruple‐blind, randomized placebo‐controlled trial taking place in the Netherlands. Target enrolment: 742 participants |
Participants | Adult (≥ 18 years) participants admitted to 1 of 6 participating ICUs and diagnosed with delirium by the CAM‐ICU or ICDSC ≥ 4 |
Interventions | Participants randomized to receive haloperidol, starting with 2.5 mg IV q8h and titrated to a maximum of 5 mg IV q8h, or placebo |
Outcomes |
Primary
Secondary
|
Starting date | February 2018 |
Contact information | Mathieu van der Jagt (m.vanderjagt@erasmusmc.nl) |
Notes | Study is currently recruiting Study sponsor: Erasmus Medical Center Rotterdam Study funded by: ZonMw Study registered: at https://www.clinicaltrialsregister.eu/ctr‐search/trial/2017‐003115‐20/NL |
APACHE: Acute Physiology and Chronic Healh Evaluation.
CAM‐ICU: Confusion Assessment Method for the ICU.
DRS‐R‐98: Delirium Rating Scale ‐ Revised ‐ 98.
DSM: Diagnostic and Statistical Manual.
EEG: electroencephalography.
EQ‐5D‐5L: EuroQoL Group Quality of Life Based on 5 Dimensions ‐ 5‐Level Scale.
ICDSC: Intensive Care Delirium Screening Checklist.
ICU: intensive care unit.
QTc: measure of time between start of the Q wave and end of the T wave in the heart's electrical cycle corrected for heart rate.
RASS: Richmond Agitation‐Sedation Scale.